TerrAscend Corp. (TSND.TO)

CAD 0.37

(1.39%)

Operating Income Summary of TerrAscend Corp.

  • TerrAscend Corp.'s latest annual operating income in 2023 was -22.99 Million USD , up 253.17% from previous year.
  • TerrAscend Corp.'s latest quarterly operating income in 2024 Q2 was 12.61 Million USD , up 9.98% from previous quarter.
  • TerrAscend Corp. reported an annual operating income of -30.9 Million USD in 2022, down -177.38% from previous year.
  • TerrAscend Corp. reported an annual operating income of 39.94 Million USD in 2021, up 181.09% from previous year.
  • TerrAscend Corp. reported a quarterly operating income of 11.47 Million USD for 2024 Q1, down -27.28% from previous quarter.
  • TerrAscend Corp. reported a quarterly operating income of 15.77 Million USD for 2023 Q4, down -25.74% from previous quarter.

Annual Operating Income Chart of TerrAscend Corp. (2023 - 2016)

Historical Annual Operating Income of TerrAscend Corp. (2023 - 2016)

Year Operating Income Operating Income Growth
2023 -22.99 Million USD 253.17%
2022 -30.9 Million USD -177.38%
2021 39.94 Million USD 181.09%
2020 -49.25 Million CAD 24.26%
2019 -65.03 Million CAD -131.0%
2018 -28.15 Million CAD -322.99%
2017 -6.65 Million CAD -667.79%
2016 -866.94 Thousand CAD 0.0%

Peer Operating Income Comparison of TerrAscend Corp.

Name Operating Income Operating Income Difference
Aurora Cannabis Inc. -46.45 Million CAD 50.496%
Avicanna Inc. -7.93 Million CAD -189.877%
Avant Brands Inc. -1.45 Million CAD -1484.838%
Cardiol Therapeutics Inc. -29.78 Million CAD 22.795%
Crescita Therapeutics Inc. -1.95 Million CAD -1075.665%
Knight Therapeutics Inc. -2.89 Million CAD -695.709%
MediPharm Labs Corp. -18.25 Million CAD -25.992%
OrganiGram Holdings Inc. -242.73 Million CAD 90.526%
Canopy Growth Corporation -228.71 Million CAD 89.946%
Willow Biosciences Inc. -13.18 Million CAD -74.45%
Auxly Cannabis Group Inc. -19 Million CAD -21.0%